Barely Significant

Excerpts

514,629 sentences

a favorable trendP = 0.0470.9× alphagold
With regards to the secondary endpoint of major adverse cardiovascular events (myocardial infarction [MI], death, stroke, severe recurrent ischemia), a favorable trend was seen only with the ticagrelor 180 mg group compared with clopidogrel in terms of fewer MIs at 4 weeks (3.5% versus 1.0%; P = 0.047) and 12 weeks (5.6% versus 2.5%; P = 0.06).
marginally significantp=0.0470.9× alphagold
Results Compared with baseline, follow-up surveys showed (1) a small non-significant decrease in the mean number of people per bedroom in the house on the night before the survey (3.4, 95% CI 3.1 to 3.6 at baseline vs 3.2, 95% CI 2.9 to 3.4 at follow-up; natural logarithm transformed t test, t=1.3, p=0.102); (2) a marginally significant overall improvement in infrastructure function scores (Kruskal–Wallis test, χ 2 =3.9, p=0.047); and (3) no clear overall improvement in hygiene (Kruskal–Wallis test, χ 2 =0.3, p=0.605).
marginally significantp = 0.0470.9× alphagold
Assessment by SF-36 at D8 showed that the improvement in Quality of Life was marginally significant for the physical component (37.5 ± 7.9 vs. 42.0 ± 9.7; p = 0.047; ES = 0.88 (0.01; 1.75)) and unchanged for the mental component (36.8 ± 10.6 vs. 36.8 ± 10.2; p = 0.77; ES = 0.1 (−0.74; 0.94)).
a weakly significant differencep = 0.0470.9× alphaqualifiedgold
The two radiotracers showed a weakly significant difference in the lymph node DR, namely the lymph node region resulted positive in 28% (19/69) of [ 18 F]fluciclovine patients ( p = 0.047) and in 15% (10/69) of [ 18 F]fluorocholine patients.
an increasing trendp = 0.0470.9× alphagold
The model intercept, i.e., the initial value of dyadic coping of 112.60, showed an increasing trend in the subsequent three measurements [slope(S) = 0.228, p = 0.047], and there was a significant correlation between the intercept and the slope ( r = −0.488, p < 0.001), suggesting that there was a significant negative correlation between the initial state of dyadic coping in patients with malignant bone tumors and the speed of development, i.e., the higher the initial level of dyadic coping in patients with malignant bone tumors, the slower the rate of increase in the later stage ( Figure 3 ).